Biotechnology company Biocon's arm Syngene International on Tuesday debuted at the stock market with a rise of 26 percent over its issue price of Rs 250. Company Shares rose as soon as the trading bell rang at the BSE and soon shot up to Rs 315. The company's initial public offering opened on July 27 and closed on July 29. 